IGFBP2 and esophageal squamous cell carcinoma: Knockdown of MT2A inhibited the expression and secretion of insulin-like growth factor binding protein 2 (IGFBP2), and recombinant IGFBP2 promoted the migration and invasion of ESCC cells through NF-κB, Akt and Erk signaling pathways (57).